Everett Harris & Co. CA Increases Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Everett Harris & Co. CA raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 28.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,987 shares of the company’s stock after acquiring an additional 13,847 shares during the quarter. Everett Harris & Co. CA’s holdings in Bath & Body Works were worth $2,442,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. FMR LLC grew its stake in Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after purchasing an additional 2,501,828 shares during the period. KBC Group NV increased its stake in shares of Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after acquiring an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH purchased a new position in Bath & Body Works during the 3rd quarter valued at about $50,483,000. Assenagon Asset Management S.A. boosted its stake in Bath & Body Works by 723.4% during the third quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock worth $37,268,000 after acquiring an additional 1,025,757 shares in the last quarter. Finally, Senvest Management LLC purchased a new stake in Bath & Body Works in the third quarter worth about $30,537,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Down 2.0 %

Shares of NYSE:BBWI opened at $37.60 on Friday. The stock has a 50 day moving average of $37.55 and a 200 day moving average of $33.68. The company has a market cap of $8.14 billion, a PE ratio of 9.17, a price-to-earnings-growth ratio of 1.01 and a beta of 1.82. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.48 earnings per share. Equities research analysts predict that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.13%. Bath & Body Works’s payout ratio is 19.51%.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of analyst reports. TD Cowen boosted their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Wells Fargo & Company raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Barclays lifted their price target on Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. Morgan Stanley cut their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Finally, Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.